Zosano Pharma Corporation (ZSAN)
US98979H3012 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 220K | 790K 259.09% | 204K -74.18% | -100.00% | ||||
| EBITDA YoY % growth | -36.52M -7.07% | -31.33M 14.21% | -29.78M 4.95% | -13.295M 55.36% | -15.887M -19.50% | -18.501M -16.46% | -21.976M -18.78% | |
| EBIT YoY % growth | -37.2M -6.68% | -32.76M 11.94% | -31.53M 3.75% | -15.311M 51.44% | -16.548M -8.08% | -19.658M -18.79% | -23.819M -21.17% | |
| Operating Margin | N/A | -14,890.91% | -3,991.14% | -7,505.50% | N/A | N/A | N/A | |
| EPS YoY % growth | -2.34 98.15% | -0.57 75.64% | -6.73 -1,080.70% | -0.09 98.64% | -0.09 | -0.13 -46.56% | -0.20 -49.50% |
| Q2 / 22 | Q3 / 22 | Q4 / 22 | |
|---|---|---|---|
| EPS Q2Q % growth | -0.02 99.03% | -0.01 99.58% | -0.01 99.51% |
| Revenue Q2Q % growth | 102K -46.32% | -100.00% | -100.00% |
| EBITDA Q2Q % growth | -3.138M 55.81% | -1.852M 74.56% | -1.85M 64.21% |
| EBIT Q2Q % growth | -3.635M 54.39% | -2.276M 73.54% | -2.275M 67.13% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2022 Q2Q % growth | -1.76 -2,100.00% | -1.79 | 0.03 | 1.40% |
| Q4 2021 Q2Q % growth | -2.10 -2,525.00% | -1.61 | -0.49 | -30.72% |
| Q3 2021 Q2Q % growth | -2.45 -2,127.27% | -2.74 | 0.29 | 10.49% |
| Q2 2021 Q2Q % growth | -2.10 -1,400.00% | -2.74 | 0.64 | 23.28% |
| Q1 2021 Q2Q % growth | -0.08 66.67% | -0.08 | 0.00 | -2.30% |
| Q4 2020 Q2Q % growth | -0.08 82.22% | -0.10 | 0.02 | 17.44% |
| Q3 2020 Q2Q % growth | -0.11 80.00% | -0.10 | -0.01 | -11.56% |
| Q2 2020 Q2Q % growth | -0.14 74.55% | -0.14 | 0.00 | 1.96% |
| Q1 2020 Q2Q % growth | -0.24 69.62% | -0.26 | 0.02 | 7.12% |
| Q4 2019 Q2Q % growth | -0.45 47.06% | -0.48 | 0.03 | 7.12% |
| Q3 2019 Q2Q % growth | -0.55 19.12% | -0.59 | 0.04 | 7.56% |
| Q2 2019 Q2Q % growth | -0.55 26.67% | -0.57 | 0.02 | 4.28% |
| Q1 2019 Q2Q % growth | -0.79 | -0.80 | 0.01 | 0.70% |
| Q4 2018 Q2Q % growth | -0.85 | -0.70 | -0.15 | -20.77% |
| Q3 2018 Q2Q % growth | -0.68 | -0.71 | 0.03 | 4.76% |
| Q2 2018 Q2Q % growth | -0.75 | -0.91 | 0.16 | 17.38% |
Reported revenue can not be compared with estimates as they are in different currencies. Reported data is in USD, while estimates are .
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2022 Q2Q % growth | 130K -50.00% | 102K | 28K | 27.45% |
| Q4 2021 Q2Q % growth | 90K -59.09% | 1.53M | -1.44M | -94.12% |
| Q3 2021 Q2Q % growth | 250K | 265.2K | -15.2K | -5.73% |
| Q2 2021 Q2Q % growth | 190K | 261.803K | -71.803K | -27.43% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A |
| Revenue | N/A | N/A | N/A | N/A |